Covid-19: 2nd sero survey round begins in Delhi to take stock of situation

The second round of sero-prevalence survey began in the national capital on Saturday, with the five-day exercise set to cover all districts and various demographic segments

Patients attend the morning Yoga session, organised by the ITBP at Sardar Patel Covid Care Centre and Hospital in New Delhi
Patients attend the morning Yoga session, organised by the ITBP at Sardar Patel Covid Care Centre and Hospital in New Delhi
Press Trust of India New Delhi
2 min read Last Updated : Aug 01 2020 | 6:31 PM IST

The second round of sero-prevalence survey began in the national capital on Saturday, with the five-day exercise set to cover all districts and various demographic segments.

The exercise is being undertaken for a comprehensive assessment of the COVID-19 situation in Delhi.

The survey has begun and samples will be collected from four districts, including North Delhi and Northwest Delhi, to start with on Saturday.

A senior government official said 15,000 samples would be collected from August 1 to 5 as part of the exercise, spanning different areas and age groups. Representative samples will be taken from all the 11 districts.

A sero-prevalence survey involves testing the blood serum of individuals to check for the prevalence of antibodies against infection.

Delhi Health Minister Satyendar Jain on July 22 had announced that after analysing the results of the last survey, it was decided that more such exercises would be undertaken every month to formulate better policies for tackling the COVID-19 situation in the city.

The last sero-prevalence survey was conducted by the Delhi government in association with the National Centre for Disease Control (NCDC) from June 27 to July 10. The second round would follow the same protocol as that was for the last survey, officials said.

The Delhi health department has prepared a detailed plan under which every district medical officer has been asked to conduct the survey in their respective jurisdictions, they said.

All CDMOs have been tasked with carrying out the survey in their districts. Random people will be tested for antibodies.

The last sero-prevalance survey had found that around 23 per cent of the people surveyed had been exposed to the novel coronavirus, the central government had said.

The previous study had tested 21,387 samples.

The Delhi government had decided to conduct more monthly sero surveys to find a greater percentage of such people who had got infected and recovered so as to formulate better policies for tackling COVID-19, Jain had said.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :DelhiCOVID-19

First Published: Aug 01 2020 | 6:28 PM IST

Next Story